Alveo Technologies Begins Shipping the First Point-of-Need Molecular Test for Avian Influenza in Poultry to the EU | PR Newswire [Video]

Chris Cowen, seasoned global commercial executive in Life Sciences, joins as Chief Commercial Officer to drive future growth and scale

, /PRNewswire/ — Alveo Technologies, Inc. (Alveo), a leader in decentralized molecular diagnostics with its proprietary IntelliSense™ platform, today announced the launch of its first animal health diagnostic product, the Alveo Sense Avian Influenza Test. The Alveo Sense Avian Influenza Panel provides fast, precise results in the field with geotagged results and cloud-based analytics immediately accessible in the cloud.

The product is launching in partnership with Netherlands-based Royal GD, a leading organization in the field of animal health, monitoring, and improvement of animal health in livestock farming as well as UK-based x-OvO. The first shipments are now reaching early-access customers across the EU through established sales channels, with further expansion planned throughout the EMEA region.

With this launch, Alveo has positioned itself for rapid growth with a significant expansion beyond human health. To manage this growth, …